SCN9A and diabetic neuropathy: For example, in the context of diabetic neuropathy, several different genetic approaches revealed rare NaV1.7 variants in 9% of patients affected by painful diabetic neuropathy (PDN); these patients reported more pain and higher sensitivity to mechanical stimuli on quantitative sensory testing compared to others in their cohort (Blesneac et al., 2018).